Christine L Hann

15PUBLICATIONS
149CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 23, 2026
Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study.

|Apr 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer.

|Apr 19, 2026
plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

|Mar 16, 2026
TNIK overexpression is sufficient for chemoradiation resistance in limited-stage small cell lung cancer.

Dipanwita Dutta Chowdhury, Eddie L Imada, Nick Connis

|Dec 04, 2025
Inhibition of CDKs Enhances the Efficacy of Anti-EGFR Therapy in Chordoma.

Tianna Zhao, Riccardo Serra, Michelle Guo

|Jun 10, 2024
TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy.

Triet Nguyen, Francesca A Carrieri, Nick Connis

Pageof 3

Frequent Collaborators

6 joint publications

Valsamo Anagnostou

6 joint publications

Susan Scott

5 joint publications

Vincent K Lam

5 joint publications

Joseph C Murray